REQUINATE

USPTO USPTO 2003 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark REQUINATE was filed as Word mark on 06/13/2003 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 03/06/2007. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details

Trademark form Word mark
File reference 78262195
Register number 3214652
Application date June 13, 2003
Publication date September 5, 2006
Entry date March 6, 2007

Trademark owner

The Oxford Science Park
OX4 4GA Oxford
GB

Trademark representatives

goods and services

1 Chemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology
5 Gene therapy and prophylaxis products, namely, gene delivery, gene transfer, gene regulation and gene modulation for the treatment of hemophilia, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders
42 Scientific and medical research and development; engineering services; biotechnology services, namely, research for others in the field of biotechnology, biotechnology research in the development of therapeutic and prophylactic products and vaccines; licensing of intellectual property; advisory services relating to the research and development of gene therapy and prophylaxis products; consultation services in the field of medical and scientific research in the field of professional gene therapy; medical research and development in the field of vector production technologies

ID: 1378262195